Stryker Corp. (SYK) intrinsic value & 10-year financials

Stryker Corp. (SYK) has a Graham intrinsic value of $171.61 per share. At $294.66 on Oct 17, 2026, the stock trades 72% above that value. Over the last 10 fiscal years revenue grew 9.2% a year to $25.1B, with an average return on invested capital of 11.4%.

Graham intrinsic value
$171.61
Share price (Oct 17, 2026)
$294.66
Price vs Graham value
72% above
Market cap
$113.9B
Revenue (FY2025)
$25.1B
Revenue growth (10-yr CAGR)
9.2%
ROIC (10-yr avg)
11.4%
Free cash flow (FY2025)
$4.3B

SYK 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $25.1B $3.2B $8.40 $4.3B 19.5% 11.1%
FY2024 $22.6B $3.0B $7.76 $3.5B 16.3% 11.2%
FY2023 $20.5B $3.2B $8.25 $3.1B 19.0% 12.4%
FY2022 $18.4B $2.4B $6.17 $2.0B 15.4% 9.7%
FY2021 $17.1B $2.0B $5.21 $2.7B 15.1% 9.3%
FY2020 $14.4B $1.6B $4.20 $2.8B 15.5% 8.5%
FY2019 $14.9B $2.1B $5.48 $1.5B 18.2% 12.4%
FY2018 $13.6B $3.6B $9.34 $2.0B 18.7% 16.6%
FY2017 $12.4B $1.0B $2.68 $961.0M 18.4% 8.4%
FY2016 $11.3B $1.6B $4.35 $1.3B 19.1% 14.2%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Stryker Corporation is a consistent compounder, expanding top-line revenue at 9.3% annually over the past decade.

Stryker Corporation returns on capital have been average, hovering around 11.4% ROIC over the decade.

Over the decade, Stryker Corporation shows that the company has leveraged its balance sheet to sustain operations.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Stryker Corporation is modeled at 7.6% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $171.61 per share.

SYK stock: frequently asked questions

What is the intrinsic value of Stryker Corp. (SYK) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 7.6% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, SYK's intrinsic value is about $171.61 per share.

Is SYK stock undervalued?

At $294.66 (close on Oct 17, 2026), SYK trades 72% above its Graham value of $171.61. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has Stryker Corp. grown?

Revenue went from $11.3B in fiscal 2016 to $25.1B in fiscal 2025, a compound annual growth rate of 9.2%. Net income was $3.2B in fiscal 2025.

Does Stryker Corp. generate free cash flow?

Stryker Corp. generated $4.3B of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 10 of the last 10 reported years.

What is SYK's return on invested capital?

Average ROIC over the last 10 fiscal years was 11.4%, and average return on equity was 16.7%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this SYK data come from?

From Stryker Corp.'s annual 10-K filings on SEC EDGAR. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar surgical & medical instruments & apparatus stocks